IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Based on more than six months of additional monitoring, data show continued…
Tag: Nasdaq:IMNN
Based on more than six months of additional monitoring, data show continued…
